Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metabolic Imaging in B-Cell Lymphomas during CAR-T Cell Therapy

27 Sept 2022

Abstract excerpt

Chimeric antigen receptor–engineered (CAR) T cells are emerging powerful therapies for patients with refractory/relapsed B-cell lymphomas. [18F]FDG PET/CT plays a key role during staging and response assessment in patients with lymphoma; however, the evidence about its utility in CAR-T therapies for lymphomas is limited. This review article aims to provide an overview of the role of PET/CT during CAR-T cell...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Viral Infectious Diseases and Gene Expression in Insects
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36230629
DOI: 10.3390/cancers14194700

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metabolic Imaging in B-Cell Lymphomas during CAR-T Cell TherapyPMID 36230629Read ↗

Molecular imaging in lymphoma beyond 18F-FDG-PET: understanding the biology and its implications for diagnostics and therapySemantic proximity Read ↗

Combination of baseline PET/CT total metabolic tumor volume, lesion dissemination and TP53 mutations predicts rapid progression of diffuse large B-cell lymphomaSemantic proximity Read ↗

Molecular Imaging in Immunotherapy: A Systematic ReviewSemantic proximity Read ↗

Diagnostic Value of PET/CT and Maximum Standardized Uptake Value in Patients with Primary LymphomaSemantic proximity Read ↗

Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma-indicator for treatment-induced immune activation?Semantic proximity Read ↗

Molecular PET imaging: Unlocking the secrets of cancer metabolismSemantic proximity Read ↗

PET/CT imaging: The incremental value of assessing the glucose metabolic phenotype and the structure of cancers in a single examination.Semantic proximity Read ↗

Circulating tumor DNA in diffuse large B-cell lymphoma: analysis of response assessment, correlation with PET/CT and clone evolutionSemantic proximity Read ↗

Clinico-pathological factors and 18 F-FDG PET/CT metabolic parameters for prediction of progression-free survival in Radioiodine Refractory Differentiated Thyroid CarcinomaSemantic proximity Read ↗

Discriminating Inflammation from Malignancy with Short-Dynamic Patlak Parametric 18F-FDG PET/CTSemantic proximity Read ↗

Molecular PET and PET/CT imaging of tumour cell proliferation using F-18 fluoro-L-thymidine: a comprehensive evaluationSemantic proximity Read ↗

Effects of carbidopa premedication on 18F-FDOPA PET imaging of brain tumors: a static, dynamic and radiomics analysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.